{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:31:11Z","timestamp":1789594271800,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012818","name":"Community of Madrid","doi-asserted-by":"publisher","award":["2023-T1\/SAL-GL-28980"],"award-info":[{"award-number":["2023-T1\/SAL-GL-28980"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI21CIII\/00033"],"award-info":[{"award-number":["PI21CIII\/00033"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI24CIII\/00003"],"award-info":[{"award-number":["PI24CIII\/00003"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["CB21\/13\/00044"],"award-info":[{"award-number":["CB21\/13\/00044"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006301","name":"Center for International Business Education and Research, University of Illinois at Urbana-Champaign","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006301","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jiph.2025.102981","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:40:52Z","timestamp":1759009252000},"page":"102981","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Long-term effects of HCV eradication on lipid profiles associated with MASLD among people with HIV with advanced fibrosis or cirrhosis"],"prefix":"10.1016","volume":"18","author":[{"given":"Ana","family":"Virseda-Berdices","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belen","family":"Requena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Berenguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"G\u00f3nzalez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Gonzalez-Riano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"D\u00edez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Honta\u00f1\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Mu\u00f1oz-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Fern\u00e1ndez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coral","family":"Barbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Resino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rub\u00e9n","family":"Mart\u00edn-Escolano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda \u00c1ngeles","family":"Jim\u00e9nez-Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jiph.2025.102981_bib1","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1093\/cid\/ciaa502","article-title":"Persistence of clinically significant portal hypertension after eradication of hepatitis c virus in patients with advanced cirrhosis","volume":"71","author":"Diez","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jiph.2025.102981_bib2","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/hep.29071","article-title":"Eradication of hepatitis c virus and non-liver-related non-acquired immune deficiency syndrome-related events in human immunodeficiency virus\/hepatitis c virus coinfection","volume":"66","author":"Berenguer","year":"2017","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jiph.2025.102981_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jinf.2022.11.004","article-title":"Burden of significant liver damage in people living with HIV after microelimination of the hepatitis C virus","volume":"86","author":"Santos","year":"2023","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.jiph.2025.102981_bib4","first-page":"24","article-title":"Steatosis and hepatitis c","volume":"4","author":"Modaresi Esfeh","year":"2016","journal-title":"Gastroenterol Rep"},{"issue":"2","key":"10.1016\/j.jiph.2025.102981_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11020271","article-title":"Hepatitis C virus-lipid interplay: pathogenesis and clinical impact","volume":"11","author":"Elgretli","year":"2023","journal-title":"Biomedicines"},{"issue":"11-12","key":"10.1016\/j.jiph.2025.102981_bib6","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/apt.17233","article-title":"Prevalence and clinical characteristics of patients with metabolic dysfunction-associated fatty liver disease with hepatitis c virus infection-a population-based study","volume":"56","author":"Attia","year":"2022","journal-title":"Aliment Pharm Ther"},{"issue":"18","key":"10.1016\/j.jiph.2025.102981_bib7","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1042\/CS20220572","article-title":"Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways","volume":"136","author":"Badmus","year":"2022","journal-title":"Clin Sci"},{"issue":"6","key":"10.1016\/j.jiph.2025.102981_bib8","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.jhep.2021.07.035","article-title":"Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States","volume":"75","author":"Kim","year":"2021","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.jiph.2025.102981_bib9","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/jvh.13167","article-title":"Liver steatosis is a major predictor of poor outcomes in chronic hepatitis c patients with sustained virological response","volume":"26","author":"Peleg","year":"2019","journal-title":"J Viral Hepat"},{"issue":"20","key":"10.1016\/j.jiph.2025.102981_bib10","doi-asserted-by":"crossref","first-page":"15473","DOI":"10.3390\/ijms242015473","article-title":"Metabolic-dysfunction-associated steatotic liver Disease\u2014Its pathophysiology, association with atherosclerosis and cardiovascular disease, and treatments","volume":"24","author":"Yanai","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.jiph.2025.102981_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2021.08.019","article-title":"Long-term evolution in liver fibrosis and immune profile after direct-acting antivirals therapy in hepatitis c virus-human immunodeficiency virus co-infected patients","volume":"28","author":"Laguno","year":"2022","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1016\/j.jiph.2025.102981_bib12","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.jiph.2025.102981_bib13","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/apt.16346","article-title":"MAFLD considerations as a part of the global hepatitis c elimination effort: an international perspective","volume":"53","author":"Fouad","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.jiph.2025.102981_bib14","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/apt.14554","article-title":"Viral eradication reduces both liver stiffness and steatosis in patients with chronic hepatitis c virus infection who received direct-acting anti-viral therapy","volume":"47","author":"Tada","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.jiph.2025.102981_bib15","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/MEG.0000000000001106","article-title":"Changes in liver stiffness and steatosis among patients with hepatitis c virus infection who received direct-acting antiviral therapy and achieved sustained virological response","volume":"30","author":"Kobayashi","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jiph.2025.102981_bib16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jceh.2018.06.009","article-title":"Therapy with oral directly acting agents in hepatitis c infection is associated with reduction in fibrosis and increase in hepatic steatosis on transient elastography","volume":"9","author":"Rout","year":"2019","journal-title":"J Clin Exp Hepatol"},{"issue":"10","key":"10.1016\/j.jiph.2025.102981_bib17","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.dld.2020.11.001","article-title":"Metabolic comorbidities and Male sex influence steatosis in chronic hepatitis c after viral eradication by direct-acting antiviral therapy (DAAs): evaluation by the controlled attenuation parameter (CAP)","volume":"53","author":"Cespiati","year":"2021","journal-title":"Dig Liver Dis"},{"issue":"7","key":"10.1016\/j.jiph.2025.102981_bib18","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease","volume":"42","author":"Lee","year":"2010","journal-title":"Dig Liver Dis"},{"issue":"4","key":"10.1016\/j.jiph.2025.102981_bib19","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3350\/cmh.2024.0414","article-title":"Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis c patients after viral eradication: a nationwide registry study in Taiwan","volume":"30","author":"Huang","year":"2024","journal-title":"Clin Mol Hepatol"},{"issue":"7","key":"10.1016\/j.jiph.2025.102981_bib20","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/hepr.13899","article-title":"Hepatitis c virus eradication by direct-acting antivirals causes a simultaneous increase in the prevalence of fatty liver and hyper low-density lipoprotein cholesterolemia without an increase in body weight","volume":"53","author":"Tokuchi","year":"2023","journal-title":"Hepatol Res"},{"issue":"1","key":"10.1016\/j.jiph.2025.102981_bib21","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1194\/jlr.M700184-JLR200","article-title":"Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes","volume":"49","author":"Han","year":"2008","journal-title":"J Lipid Res"},{"issue":"4","key":"10.1016\/j.jiph.2025.102981_bib22","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/hep.21763","article-title":"A lipidomic analysis of nonalcoholic fatty liver disease","volume":"46","author":"Puri","year":"2007","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.jiph.2025.102981_bib23","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1021\/pr200629p","article-title":"A comprehensive untargeted metabonomic analysis of human steatotic liver tissue by RP and HILIC chromatography coupled to mass spectrometry reveals important metabolic alterations","volume":"10","author":"Garcia-Canaveras","year":"2011","journal-title":"J Proteome Res"},{"issue":"1","key":"10.1016\/j.jiph.2025.102981_bib24","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12944-021-01526-5","article-title":"Serum lipids are associated with nonalcoholic fatty liver disease: a pilot case-control study in Mexico","volume":"20","author":"Flores","year":"2021","journal-title":"Lipids Health Dis"},{"issue":"10","key":"10.1016\/j.jiph.2025.102981_bib25","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.cgh.2016.05.046","article-title":"Noninvasive detection of nonalcoholic steatohepatitis using clinical markers and circulating levels of lipids and metabolites","volume":"14","author":"Zhou","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.jiph.2025.102981_bib26","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.dld.2024.05.015","article-title":"Metabolic signatures of metabolic dysfunction-associated steatotic liver disease in severely obese patients","volume":"56","author":"Babu","year":"2024","journal-title":"Dig Liver Dis"},{"issue":"1","key":"10.1016\/j.jiph.2025.102981_bib27","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.25630","article-title":"Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis","volume":"56","author":"Tanaka","year":"2012","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jiph.2025.102981_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/nu14030579","article-title":"Lysophosphatidylethanolamine affects lipid accumulation and metabolism in a human Liver-Derived cell line","volume":"14","author":"Yamamoto","year":"2022","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.jiph.2025.102981_bib29","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1194\/jlr.P056002","article-title":"Biomarkers of NAFLD progression: a lipidomics approach to an epidemic","volume":"56","author":"Gorden","year":"2015","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.jiph.2025.102981_bib30","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00216-020-02996-9","article-title":"Analysis of serum lysophosphatidylethanolamine levels in patients with non-alcoholic fatty liver disease by liquid chromatography-tandem mass spectrometry","volume":"413","author":"Yamamoto","year":"2021","journal-title":"Anal Bioanal Chem"},{"issue":"5","key":"10.1016\/j.jiph.2025.102981_bib31","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3390\/nu10050649","article-title":"Circulating phospholipid patterns in NAFLD patients associated with a combination of metabolic risk factors","volume":"10","author":"Tiwari-Heckler","year":"2018","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.jiph.2025.102981_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/srep46658","article-title":"Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients","volume":"7","author":"Chiappini","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jiph.2025.102981_bib33","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1186\/s12967-023-04367-1","article-title":"Mitochondrial metabolic dysfunction and non-alcoholic fatty liver disease: new insights from pathogenic mechanisms to clinically targeted therapy","volume":"21","author":"Zheng","year":"2023","journal-title":"J Transl Med"},{"issue":"Pt 5","key":"10.1016\/j.jiph.2025.102981_bib34","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1099\/vir.0.83491-0","article-title":"Activation of sterol regulatory element-binding protein 1c and fatty acid synthase transcription by hepatitis c virus non-structural protein 2","volume":"89","author":"Oem","year":"2008","journal-title":"J Gen Virol"},{"issue":"3","key":"10.1016\/j.jiph.2025.102981_bib35","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s11695-018-3612-2","article-title":"A pilot study of serum sphingomyelin dynamics in subjects with severe obesity and Non-alcoholic steatohepatitis after sleeve gastrectomy","volume":"29","author":"Ramos-Molina","year":"2019","journal-title":"Obes Surg"},{"issue":"9","key":"10.1016\/j.jiph.2025.102981_bib36","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1111\/liv.14580","article-title":"Plasma metabolomic fingerprint of advanced cirrhosis stages among HIV\/HCV-coinfected and HCV-monoinfected patients","volume":"40","author":"Salguero","year":"2020","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.jiph.2025.102981_bib37","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.cmet.2024.01.011","article-title":"DGAT2 inhibition blocks SREBP-1 cleavage and improves hepatic steatosis by increasing phosphatidylethanolamine in the ER","volume":"36","author":"Rong","year":"2024","journal-title":"Cell Metab"},{"issue":"4","key":"10.1016\/j.jiph.2025.102981_bib38","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/hep.32647","article-title":"Essential lipid autacoids rewire mitochondrial energy efficiency in metabolic dysfunction-associated fatty liver disease","volume":"77","author":"L\u00f3pez-Vicario","year":"2023","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jiph.2025.102981_bib39","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/oby.2003.53","article-title":"Medium-chain triglycerides increase energy expenditure and decrease adiposity in overweight men","volume":"11","author":"St-Onge","year":"2003","journal-title":"Obes Res"},{"key":"10.1016\/j.jiph.2025.102981_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2021.100104","article-title":"Nonalcoholic fatty liver disease stratification by liver lipidomics","volume":"62","author":"Vvedenskaya","year":"2021","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jiph.2025.102981_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103661","article-title":"The altered serum lipidome and its diagnostic potential for non-alcoholic fatty liver (NAFL)-associated hepatocellular carcinoma","volume":"73","author":"Lewinska","year":"2021","journal-title":"EBioMedicine"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034125003302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034125003302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T16:06:43Z","timestamp":1773158803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034125003302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1876034125003302"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2025.102981","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term effects of HCV eradication on lipid profiles associated with MASLD among people with HIV with advanced fibrosis or cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2025.102981","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}],"article-number":"102981"}}